What is IMPACT?
IMPACT is a 12-week accelerator program that uses a unique 1:1 approach and is created to connect startups with resources needed for commercialization. Selected companies will have the opportunity to engage with our sponsors' specialized research calls to help advance their business.
For Cycle 3 of the IMPACT Accelerator program, we are working with the life sciences company Hologic.
Hologic's Areas of Interest:
Devices intended to simplify and improve therapeutic procedures in the women’s health space, filling treatment gaps and advancing patient care. Areas of interest include:
• GYN transvaginal procedures, such as:
o Tubal obstruction (HSG, selective HSG)
o Biopsy collection
o Vaginal Surgery
• GYN Laparoscopic surgery
• Pelvic organ prolapse
• Pelvic/bladder health
• Contraception (non-hormonal)
• Fertility
• Oncology solutions
• Surgical approaches to oncology
How our past members feel about the IMPACT program.
The content of the live events was excellent, and the support and encouragement offered by M2D2’s leadership team was exceptional."
The IMPACT team assisted with key introductions to investors and strategic partners."
We were thrilled to be accepted into the program, and our expectations were only exceeded."
The accelerator had a positive impact on Avisi and we highly recommend it to other startups like us.”
We would recommend the IMPACT program to any startup willing to learn and advance their company to the next level.”
I cannot recommend M2D2 IMPACT enough.”
Join us in person for the IMPACT Cycle 3 Pitch-Off!
Thursday, July 21st • 4-8 pm • 110 Canal Street, 4th Fl., Lowell MA
Join the Massachusetts life sciences community in Lowell as the startups from the Cycle 3 Cohort pitch their medical device solution to a panel of judges.
You'll hear new, innovative ideas, connect with medical device experts and enjoy delicious food and drink during the event.
IMPACT Video Testimonial
Learn about the IMPACT experience first-hand from alumni Hubly Surgical and their CEO Casey Grage.
Subscribe
Sign up to our newsletter and stay up to date